Last Updated: May 6, 2026

CLOPIDOGREL Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Clopidogrel, and when can generic versions of Clopidogrel launch?

Clopidogrel is a drug marketed by Accord Hlthcare, Acme Labs, Actavis Totowa, Alkem Labs Ltd, Amneal Pharms, Ani Pharms, Apotex Inc, Aurobindo Pharma Ltd, Chartwell Rx, Dr Reddys, Dr Reddys Labs Ltd, Hetero Labs Ltd V, Macleods Pharms Ltd, MSN, Prinston Inc, Puracap Labs Blu, Rising, Sciegen Pharms, Sun Pharm, Sun Pharm Industries, Teva, Torrent Pharms Ltd, and Zydus Lifesciences. and is included in twenty-five NDAs.

The generic ingredient in CLOPIDOGREL is clopidogrel bisulfate. There are fifty-four drug master file entries for this compound. Thirty-six suppliers are listed for this compound. Additional details are available on the clopidogrel bisulfate profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Clopidogrel

A generic version of CLOPIDOGREL was approved as clopidogrel bisulfate by DR REDDYS on January 14th, 2008.

  Start Trial

AI Deep Research
Questions you can ask:
  • What is the 5 year forecast for CLOPIDOGREL?
  • What are the global sales for CLOPIDOGREL?
  • What is Average Wholesale Price for CLOPIDOGREL?

US Patents and Regulatory Information for CLOPIDOGREL

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Teva CLOPIDOGREL BISULFATE clopidogrel bisulfate TABLET;ORAL 076999-001 May 17, 2012 AB RX No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Sciegen Pharms CLOPIDOGREL BISULFATE clopidogrel bisulfate TABLET;ORAL 204165-001 Sep 15, 2014 AB RX No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Torrent Pharms Ltd CLOPIDOGREL BISULFATE clopidogrel bisulfate TABLET;ORAL 090844-001 May 17, 2012 AB RX No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.